“Some of the genes that contribute to the normal variation of tooth dimensions among healthy people can also contribute to pathogenic variation, such as teeth failing to grow in or other dental health conditions,” according to first author Qing Li, PhD, from Fudan University.

“We hope that our findings could be useful medically, if people with particular dental problems could undergo genetic tests to help in diagnosis, or if some dental anomalies could be treated one day with gene therapies.”
“Teeth can tell us a great deal about human evolution, as well-preserved ancient teeth are particularly important to archaeologists, shedding light on milestones such as when we transitioned to cooked food and human tooth sizes began to shrink,” said co-lead author Kaustubh Adhikari, PhD, University College London (UCL), genetics, evolution, and environment, and the Open University.
“But little is known about the genetic basis of variation within the modern human population on tooth size and shape, partly due to challenges in measuring teeth. We have now identified numerous genes that impact the development of our teeth, some of which are responsible for differences between ethnic groups.”
The study used data from 882 volunteers in Colombia, of mixed European, Native American, and African ancestry, including dental crown measurements (dimensions of the part of the tooth visible above the gums), derived from 3D scans of dental plaster casts. The researchers compared these measurements with the participants’ genetic information in a genome-wide association study, using an analysis approach called multiomics that brings together numerous data sources.
The international team, led by researchers at UCL, the Open University, Fudan University (China), Aix-Marseille University (France), and the National University of La Plata (Argentina), identified 18 genome regions that influence the size and shape of different groups of teeth, 17 of which had not been previously linked to tooth dimensions.
Interbreeding with ancient humans
One of the novel associations was on a gene believed to be inherited from Neanderthals due to interbreeding with ancient humans. This genetic variant, which contributes to the biological pathway of tooth development, was only found in those of European descent, and carriers of the variant have thinner incisors (the eight teeth situated at the front of the mouth were measured from back to front). On the whole, those of European descent had smaller teeth.
The scientists also found associations with tooth dimensions on a gene, EDAR, that was already known to impact incisor shape in East Asian people, while the new study found that the gene also determined the width of all teeth.
“Our findings did not shed light on whether the genes that identify tooth shape were selected in evolution due to particular advantages to dental health, so it’s possible that the genes may have been selected due to the influences they have in other areas, with tooth shape differences resulting as a side effect,” pointed out co-lead author Andres Ruiz-Linares, UCL, genetics, evolution, and environment, Fudan University, and Aix-Marseille University.
https://www.genengnews.com/topics/omics/genes-that-determine-tooth-shape-identified-including-one-inherited-from-the-neanderthals/

Check out our AAV CDMO service to expedite your gene therapy research
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.
Related News
Navega Therapeutics Receives $4 Million CIRM Grant to Advance Epigenetic Gene Therapy for Chronic Pain
SAN DIEGO, CA – February 4, 2025 – Navega Therapeutics, a pioneering biotechnology company developing cutting-edge epigenetic gene therapies, today announced a significant milestone with the receipt of a $4 million Translational Science grant from the California...
Akribion Therapeutics Secures €8 Million in Seed Financing to Advance Novel RNA-Guided Cell Depletion Technology
ZWINGENBERG, Germany, February 4, 2025 – Akribion Therapeutics, a biotechnology company pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announced the closing of an €8 million Seed financing round. The round was led by...
UF-Kure19 CAR-T Cell Therapy Demonstrates High CR Rates, Low Toxicity in R/R NHL
Treatment with UF-Kure19, a rapidly manufactured CAR T-cell therapy, led to complete responses (CR) and low toxicity in patients with relapsed/refractory non-Hodgkin lymphoma, according to data from a single-arm, mult-center phase 1 study (NCT05400109) presented at...
Opinion: Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio—have products in the pipeline that could improve treatment options for this rare disease. Hunter syndrome is a rare, X‐linked disease caused by a deficiency of the lysosomal enzyme...
Related Services

AAV Packaging Services
READ MORE

Off-the-Shelf AAV Products
READ MORE